• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非转移性阑尾上皮癌复发的预测因素:25年单中心最新经验

Predictors of Recurrence in Nonmetastatic Appendiceal Epithelial Cancers: An Updated Single-Center Experience Over 25 Years.

作者信息

Aguirre Nicole, Chung Sebastian K, Foote Michael B, Shia Jinru, Vakiani Efsevia, Gowda Tina, Paty Philip B, Weiser Martin R, Garcia-Aguilar Julio, Karagkounis Georgios, Cercek Andrea, Nash Garrett M

机构信息

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Ann Surg Oncol. 2025 Feb;32(2):695-702. doi: 10.1245/s10434-024-16366-7. Epub 2024 Nov 27.

DOI:10.1245/s10434-024-16366-7
PMID:39604747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11813631/
Abstract

BACKGROUND

Appendiceal epithelial tumors are rare and encompass a broad set of adenocarcinoma histologies, including mucinous (mAC), colonic-type (cAC), and goblet cell (GCA) adenocarcinomas. It has previously been reported that nodal disease predicted recurrence in patients with nonmetastatic appendiceal adenocarcinomas, supporting diagnostic laparoscopy with right hemicolectomy for staging and assessment for risk of recurrence. In this update, we sought to identify predictors of nodal disease on initial diagnostic pathology in nonmetastatic adenocarcinomas.

METHODS

Patients with nonmetastatic appendiceal adenocarcinoma at a single institution from 1994 to 2020 were included. Clinicopathologic characteristics that predict recurrence and lymph node metastasis were analyzed. Workup included staging laparoscopy with right hemicolectomy, seriel imaging and biochemical monitoring.

RESULTS

A total of 147 patients with mAC (18%), cAC (22%), and GCAs (59%) were included. After median follow-up of 53 months, 23 (16%) patients recurred, most commonly in the peritoneal cavity (17/23, 74%). Recurrence rates were higher among node-positive patients (59% vs. 5%, P < 0.001). Nodal disease was more common in mAC (27%) and cAC (37%) than in GCA (11%); however, adenocarcinoma grade was not associated with nodal involvement.

CONCLUSIONS

Nodal metastasis was more common in mAC and cAC compared with GCA and was the only significant predictor of recurrence in appendix cancer.

摘要

背景

阑尾上皮肿瘤较为罕见,涵盖多种腺癌组织学类型,包括黏液性(mAC)、结肠型(cAC)和杯状细胞(GCA)腺癌。此前有报道称,淋巴结疾病可预测非转移性阑尾腺癌患者的复发情况,支持采用诊断性腹腔镜联合右半结肠切除术进行分期及复发风险评估。在本次更新中,我们试图确定非转移性腺癌初始诊断病理中淋巴结疾病的预测因素。

方法

纳入1994年至2020年在单一机构就诊的非转移性阑尾腺癌患者。分析预测复发和淋巴结转移的临床病理特征。检查包括分期腹腔镜联合右半结肠切除术、系列影像学检查和生化监测。

结果

共纳入147例mAC(18%)、cAC(22%)和GCA(59%)患者。中位随访53个月后,23例(16%)患者复发,最常见于腹腔(17/23,74%)。淋巴结阳性患者的复发率更高(59%对5%,P<0.001)。淋巴结疾病在mAC(27%)和cAC(37%)中比在GCA(11%)中更常见;然而,腺癌分级与淋巴结受累无关。

结论

与GCA相比,mAC和cAC中的淋巴结转移更为常见,并且是阑尾癌复发的唯一重要预测因素。

相似文献

1
Predictors of Recurrence in Nonmetastatic Appendiceal Epithelial Cancers: An Updated Single-Center Experience Over 25 Years.非转移性阑尾上皮癌复发的预测因素:25年单中心最新经验
Ann Surg Oncol. 2025 Feb;32(2):695-702. doi: 10.1245/s10434-024-16366-7. Epub 2024 Nov 27.
2
Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review.淋巴结转移在70例1-3期阑尾癌单中心经验中预测疾病复发:一项回顾性研究。
Ann Surg Oncol. 2015 Oct;22(11):3613-7. doi: 10.1245/s10434-015-4415-5. Epub 2015 Feb 7.
3
Insights into the Clinical Prognosis of High-grade Appendiceal Mucinous Neoplasms.高级别阑尾黏液性肿瘤的临床预后洞察
Am J Surg Pathol. 2025 May 1;49(5):499-507. doi: 10.1097/PAS.0000000000002373. Epub 2025 Feb 20.
4
Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies.阑尾腺癌的切除范围及长期预后:基于监测、流行病学和最终结果(SEER)数据库对黏液性和非黏液性组织学类型的分析
Ann Surg Oncol. 2024 Jul;31(7):4203-4212. doi: 10.1245/s10434-024-15233-9. Epub 2024 Apr 9.
5
Who should get a right colectomy in low-grade appendiceal adenocarcinomas? Association of lymphovascular invasion and nodal metastases.在低级别阑尾腺癌中,谁应该接受右结肠切除术?淋巴管浸润和淋巴结转移的相关性。
Surgery. 2024 Sep;176(3):560-568. doi: 10.1016/j.surg.2024.05.040. Epub 2024 Jul 9.
6
Role of right hemicolectomy in patients with low-grade appendiceal mucinous adenocarcinoma.右半结肠切除术在低级别阑尾黏液性腺癌患者中的作用。
Am J Surg. 2019 Dec;218(6):1239-1243. doi: 10.1016/j.amjsurg.2019.07.035. Epub 2019 Jul 25.
7
Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much?阑尾黏液腺癌行右半结肠切除术:恰到好处还是过度治疗?
Ann Surg Oncol. 2013 Apr;20(4):1063-7. doi: 10.1245/s10434-012-2783-7. Epub 2013 Mar 2.
8
Role of colectomy in the management of appendiceal tumors: a retrospective cohort study.盲肠切除术在阑尾肿瘤治疗中的作用:一项回顾性队列研究。
BMC Gastroenterol. 2023 Nov 17;23(1):398. doi: 10.1186/s12876-023-03019-4.
9
Importance of histologic subtype in the staging of appendiceal tumors.阑尾肿瘤分期中组织学亚型的重要性。
Ann Surg Oncol. 2012 May;19(5):1379-85. doi: 10.1245/s10434-012-2238-1.
10
Clinicopathological spectrums and prognosis of primary appendiceal adenocarcinoma, goblet cell adenocarcinoma, and low-grade appendiceal mucinous neoplasms.原发性阑尾腺癌、杯状细胞腺癌及低级别阑尾黏液性肿瘤的临床病理谱及预后
Pathology. 2023 Apr;55(3):375-382. doi: 10.1016/j.pathol.2022.08.004. Epub 2022 Oct 13.

引用本文的文献

1
Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancer.配对的原发性-转移性患者来源类器官和小鼠模型确定了阑尾癌腹膜转移的表型演变和可靶向依赖性。
bioRxiv. 2025 Feb 22:2025.02.17.638725. doi: 10.1101/2025.02.17.638725.
2
ASO Author Reflections: Predictors of Recurrence in Non-metastatic Appendiceal Epithelial Cancers-The Role of Staging Right Colectomy.ASO作者反思:非转移性阑尾上皮癌复发的预测因素——右半结肠切除术分期的作用
Ann Surg Oncol. 2025 Feb;32(2):713-714. doi: 10.1245/s10434-024-16479-z. Epub 2024 Nov 21.

本文引用的文献

1
Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies.阑尾腺癌的切除范围及长期预后:基于监测、流行病学和最终结果(SEER)数据库对黏液性和非黏液性组织学类型的分析
Ann Surg Oncol. 2024 Jul;31(7):4203-4212. doi: 10.1245/s10434-024-15233-9. Epub 2024 Apr 9.
2
Molecular Classification of Appendiceal Adenocarcinoma.阑尾腺癌的分子分类。
J Clin Oncol. 2023 Mar 10;41(8):1553-1564. doi: 10.1200/JCO.22.01392. Epub 2022 Dec 9.
3
Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry.
阑尾杯状细胞腺癌:一项系统综述及来自英国癌症登记处的1225例病例的发病率和生存率
Front Oncol. 2022 Jul 12;12:915028. doi: 10.3389/fonc.2022.915028. eCollection 2022.
4
Appendectomy Is Oncologically Equivalent to Right Hemicolectomy for Well-Differentiated T1 Appendiceal Adenocarcinoma.阑尾切除术与右半结肠切除术治疗分化良好的 T1 阑尾腺癌的肿瘤学效果相当。
Dis Colon Rectum. 2023 Jan 1;66(1):67-74. doi: 10.1097/DCR.0000000000002089. Epub 2022 Aug 18.
5
Omission of Right Hemicolectomy May be Safe for Some Appendiceal Goblet Cell Adenocarcinomas: A Survival Analysis of the National Cancer Database.某些阑尾杯状细胞腺癌患者可能可以安全地省略右半结肠切除术:国家癌症数据库的生存分析。
Ann Surg Oncol. 2021 Dec;28(13):8916-8925. doi: 10.1245/s10434-021-10191-y. Epub 2021 Aug 18.
6
Current Management of Appendiceal Neoplasms.阑尾肿瘤的现行治疗方法。
Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-15. doi: 10.1200/EDBK_321009.
7
Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC.探讨在接受 CRS/HIPEC 治疗的阑尾腹膜转移中,扩大突变分析的预后和治疗效用。
J Surg Oncol. 2021 Jun;123(7):1599-1609. doi: 10.1002/jso.26439. Epub 2021 Mar 5.
8
The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative.原发性阑尾腺癌腹膜转移患者术前肿瘤标志物的作用:来自美国 HIPEC 协作组的分析。
J Gastrointest Surg. 2021 Nov;25(11):2908-2919. doi: 10.1007/s11605-021-04953-y. Epub 2021 Feb 25.
9
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.细胞减灭术联合腹腔热灌注化疗与单纯细胞减灭术治疗结直肠腹膜转移瘤(PRODIGE 7):一项多中心、随机、开放标签、3 期临床试验。
Lancet Oncol. 2021 Feb;22(2):256-266. doi: 10.1016/S1470-2045(20)30599-4. Epub 2021 Jan 18.
10
Association of tumor size with prognosis in colon cancer: A Surveillance, Epidemiology, and End Results (SEER) database analysis.肿瘤大小与结肠癌预后的关系:监测、流行病学和最终结果(SEER)数据库分析。
Surgery. 2021 May;169(5):1116-1123. doi: 10.1016/j.surg.2020.11.011. Epub 2020 Dec 15.